BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7056582)

  • 1. Effect of hydrocortisone on macrophage response to lymphokine.
    Masur H; Murray HW; Jones TC
    Infect Immun; 1982 Feb; 35(2):709-14. PubMed ID: 7056582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphokine stimulated macrophages inhibit intracellular Chlamydia psittaci replication by mechanisms distinct from intracellular inhibition of Toxoplasma gondii replication.
    Byrne GI; Murray HW
    Adv Exp Med Biol; 1983; 162():361-4. PubMed ID: 6869092
    [No Abstract]   [Full Text] [Related]  

  • 3. Macrophage oxygen-dependent antimicrobial activity. III. Enhanced oxidative metabolism as an expression of macrophage activation.
    Murray HW; Cohn ZA
    J Exp Med; 1980 Dec; 152(6):1596-609. PubMed ID: 6256463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human mononuclear phagocyte antiprotozoal mechanisms: oxygen-dependent vs oxygen-independent activity against intracellular Toxoplasma gondii.
    Murray HW; Rubin BY; Carriero SM; Harris AM; Jaffee EA
    J Immunol; 1985 Mar; 134(3):1982-8. PubMed ID: 2981929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphokine activation of J774G8 cells and mouse peritoneal macrophages challenged with Toxoplasma gondii.
    Sibley LD; Krahenbuhl JL; Weidner E
    Infect Immun; 1985 Sep; 49(3):760-4. PubMed ID: 4030103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrocortisone treatment of BCG-infected mice impairs the activation and enhancement of antimicrobial activity of peritoneal macrophages.
    Stokvis H; Langermans JA; de Backer-Vledder E; van der Hulst ME; van Furth R
    Scand J Immunol; 1992 Aug; 36(2):299-305. PubMed ID: 1502497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential activation of resident macrophage subsets with two sources of lymphokine preparations.
    Tabor DR; Saluk PH
    Infect Immun; 1983 Apr; 40(1):177-83. PubMed ID: 6219956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage oxygen-dependent antimicrobial activity. IV. Role of endogenous scavengers of oxygen intermediates.
    Murray HW; Nathan CF; Cohn ZA
    J Exp Med; 1980 Dec; 152(6):1610-24. PubMed ID: 7452149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between the legionnaires' disease bacterium (Legionella pneumophila) and human alveolar macrophages. Influence of antibody, lymphokines, and hydrocortisone.
    Nash TW; Libby DM; Horwitz MA
    J Clin Invest; 1984 Sep; 74(3):771-82. PubMed ID: 6470140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro kinetics of functional parameters of macrophage activation with lymphokines and its relation to tumor cell cytostasis.
    Matsunaga K; Mashiba H
    Jpn J Exp Med; 1981 Oct; 51(5):287-92. PubMed ID: 7321254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-gamma.
    Murray HW; Spitalny GL; Nathan CF
    J Immunol; 1985 Mar; 134(3):1619-22. PubMed ID: 3918107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphokine-stimulated macrophage phagocytosis of fluorescent microspheres: a rapid new assay.
    Dunn PA; Eaton WR; Lopatin ED; McEntire JE; Papermaster BW
    J Immunol Methods; 1983 Nov; 64(1-2):71-83. PubMed ID: 6580345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment with phorbol myristate acetate inhibits macrophage activity against intracellular protozoa.
    Murray HW
    J Reticuloendothel Soc; 1982 Jun; 31(6):479-87. PubMed ID: 6288939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of lymphokine-induced macrophage microbicidal activity against Leishmania major by liposomes: characterization of the physicochemical requirements for liposome inhibition.
    Gilbreath MJ; Hoover DL; Alving CR; Swartz GM; Meltzer MS
    J Immunol; 1986 Sep; 137(5):1681-7. PubMed ID: 3745916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of macrophage antimicrobial activity by a tumor cell product.
    Szuro-Sudol A; Murray HW; Nathan CF
    J Immunol; 1983 Jul; 131(1):384-7. PubMed ID: 6408180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of Eimeria bovis and Toxoplasma gondii to oxygen intermediates and a new mathematical model for parasite killing.
    Hughes HP; Boik RJ; Gerhardt SA; Speer CA
    J Parasitol; 1989 Aug; 75(4):489-97. PubMed ID: 2760759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics and requirements for activation of macrophages for fungicidal activity: effect of protein synthesis inhibitors and immunosuppressants on activation and fungicidal mechanism.
    Brummer E; Hanson LH; Stevens DA
    Cell Immunol; 1991 Jan; 132(1):236-45. PubMed ID: 1712253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Chlamydia psittaci in oxidatively active thioglycolate-elicited macrophages: distinction between lymphokine-mediated oxygen-dependent and oxygen-independent macrophage activation.
    Byrne GI; Faubion CL
    Infect Immun; 1983 May; 40(2):464-71. PubMed ID: 6840848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endotoxin suppresses the generation of O2- and H2O2 by "resting" and lymphokine-activated human blood-derived macrophages.
    Rellstab P; Schaffner A
    J Immunol; 1989 Apr; 142(8):2813-20. PubMed ID: 2539412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of murine macrophages and a bovine monocyte cell line by bovine lymphokines to kill the intracellular pathogens Eimeria bovis and Toxoplasma gondii.
    Hughes HP; Speer CA; Kyle JE; Dubey JP
    Infect Immun; 1987 Mar; 55(3):784-91. PubMed ID: 3102381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.